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INTRODUCTION
After exposure to pathogens, naive CD4 + T helper (T H ) lymphocytes differentiate into memory and effector T H cell subsets: tissue-resident memory cells, which are mainly retained in the tissues, and central memory (T CM ) and effector memory (T EM ) cells, which recirculate between the blood and lymphoid organs or tissues, respectively (1, 2). In addition, T H cell subsets have been classified on the basis of their cytokine profile and functional properties into T H 1, T H 2, T H 17, T H * (T H 1/T H 17), regulatory T cell, and follicular helper (T FH ) T cell subsets (3, 4) . Although T lymphocytes with cytotoxic function (CTLs) are predominantly restricted to conventional major histocompatibility complex (MHC) class I-restricted CD8 + T lymphocytes, the existence of MHC class II-restricted T H cells with cytotoxic potential (CD4-CTLs) in humans, nonhuman primates, and mice has been reported for many decades (5, 6) . However, compared with the other T H subsets, the molecular and epigenetic mechanisms that drive the differentiation, maintenance, and function of human CD4-CTLs are poorly understood, mainly because of the lack of precise definition of the nature of this subset in humans.
CD4-CTLs were initially reported in humans with chronic viral infections such as human cytomegalovirus (hCMV), HIV, dengue virus (DENV), and hepatitis C virus (5, (7) (8) (9) (10) (11) (12) (13) (14) (15) . CD4-CTLs have also been detected in mouse lungs as early as 1 week after acute influenza viral infection (16, 17) . The magnitude of the CD4-CTL response has been associated with better clinical outcomes in both acute and chronic viral infections, implying that CD4-CTLs are an important component of the protective immune responses to viral infections (6) . Furthermore, expansion of CD4-CTLs has been observed in donors carrying human leukocyte antigen (HLA) alleles associated with protection from severe dengue disease (7) . Thus, eliciting a strong CD4-CTL response is considered an important goal of vaccination against certain viral infections (16, (18) (19) (20) . The highly effective yellow fever vaccine has been shown to elicit a strong CD4-CTL response, which is required for protection against fatal infection in mouse models (18) . CD4-CTLs have also been linked to protective antitumor immune responses, especially in virally induced tumors (18) .
Given the importance of CD4-CTLs in acquired cellular immunity, we present here the single-cell transcriptomic and T cell antigen receptor (TCR) analysis of circulating human CD4-CTLs. CD4-CTLs were highly enriched in the effector memory T cells expressing CD45RA (CD4-T EMRA ) subset and displayed notable intra-and interdonor heterogeneity. We show that the magnitude of CD4-T EMRA response is linked to the degree of clonal expansion and cytotoxicity profile of CD4-CTLs. Besides a comprehensive definition of the transcriptional program of conventional CD4-CTL effectors, we identified precursor cells sharing TCR clonotypes with CD4-CTL effectors that were distinguished by higher expression of the interleukin-7 receptor (IL-7R).
with previous DENV and CMV infection (5, (7) (8) (9) (10) . To capture the extent of cellular heterogeneity among human CD4-CTLs, we performed single-cell RNA sequencing (RNA-seq) in more than 9000 cells isolated ex vivo from the T EMRA subset and, as a control, in T H subsets that contain relatively fewer CD4-CTLs, such as T EM (22, 23) ], we compared the full-length transcriptome of CD4 + T lymphocytes present in T EMRA , T EM , and T CM subsets from three donors with previous DENV infection, carrying the HLA allele (DRB1*0401) previously FGFBP2  GZMH  GNLY  CX3CR1  GPR56  PFN1  CTSW  EFHD2  SAMD3  S1PR5  PRF1  SPON2  CST7  ITGAL  CCL5  GPR114  PFN1P1  GAB3  APMAP  KIF23  ITGB7  TGFBR3  VCL  FCRL6  ENC1  MYO6  PRSS23  DIP2A  TRGC2  SLAMF7  ZEB2  LAG3  SYNE1  ZNF683 
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reported to be protective against severe dengue disease (Fig. 1B and  table S1 ) (7, 24) . We found 111 "T EMRA -enriched" transcripts with significantly  higher mean expression in single cells from the T EMRA subset compared  with the T EM and T CM subsets (see Supplementary Materials and  Methods, Fig. 1B, and table S2). These included several transcripts  linked to the cytotoxic function of CD8  + T lymphocytes and natural  killer (NK) cells such as GZMB, PRF1, GZMH, GNLY, CCL4, CTSW,  FCRL6, SPON2, CX3CR1 , S1PR5, NKG7, and CD244 (Fig. 1, B and C) (6, 25) ; we confirmed the expression of some of these transcripts (CX3CR1, GPR56, CD244, CD314, KLRG1, GZMB, and PRF1) at the protein level (Fig. 1D) . Gene set enrichment analysis (GSEA) (26) and ingenuity pathway analysis (IPA) of T EMRA -enriched transcripts also revealed significant overrepresentation of cytotoxicity signature genes in the T EMRA subset (Fig. 1, E and F) . Transcripts encoding transcription factors (TFs) related to CTL function such as ZNF683 (Hobit), and Eomes and T-bet (encoded by TBX21) were also expressed at higher levels in single cells from the T EMRA subset (Fig. 1, B and C). ZNF683 has recently been shown to identify human CD4-CTLs (24) , and Eomes and T-bet appear to be important in the development of CD4-CTLs (27, 28) . These results confirm that human CD4-CTLs are highly enriched in the T EMRA subset. Coexpression analysis of T EMRA -enriched transcripts also revealed a number of genes (PFN1, PFN1P1, EFHD2, VCL, DIP2A, SYNE1, and PLEK) (29-32) whose expression was highly correlated with cytotoxicity signature genes, suggesting that the products of these genes may also play important roles in the development or function of CD4-CTLs (Fig. 1G ).
CD4-CTLs show marked clonal expansion
Given that memory CD4-CTLs are mainly generated after exposure to certain viruses such as DENV or CMV (5, 7-10), we expected to see a more restricted TCR repertoire, that is, greater clonal expansion in the CD4-T EMRA subset compared with CD4 + T lymphocytes in the T EM or T CM subsets, which harbor a more common memory pool. We performed parallel analysis of the TCR repertoire in single cells by decoding the full-length transcriptome profiles generated by the Smart-seq2 assay (33, 34) . Using the TraCeR software (35), we reconstructed the TCR chains in 41 to 89% of single cells, the TCR chain in 31 to 81%, and both chains in 22 to 70% of cells across all memory subsets (table S3). As expected, a greater clonal expansion was observed in the T EMRA subset compared with other subsets, as shown by highly interconnected clonotype network graphs for single cells from donor #6 (Fig. 2A) . Furthermore, the analysis of single cells that shared TCR or TCR chain clonotypes showed that more than 50% of cells in the T EMRA subset were clonally expanded (Fig. 2B , left and middle). To address the rare possibility of independent cells sharing one of the TCR chains, we also analyzed single cells that shared both TCR and TCR chain clonotypes and found that ~46% of cells in the T EMRA subset (CD4-CTL-enriched) were clonally expanded compared with only ~5% and none of the cells in T EM and T CM subsets, respectively (Fig. 2B , right, and table S4). Together, these results suggested a highly restricted TCR repertoire in the T EMRA subset (Fig. 2, A and B) . The clonally expanded cells had a higher mean expression of cytotoxic signature genes (T EMRA -enriched gene set) (Fig. 2, C and D) , suggestive of greater effector potential (6, 25, 36) .
To probe the pathogen specificity of clonally expanded CD4-T EMRA cells (CD4-CTL-enriched), we first determined the TCR clonotype of single cells in the CD4-T EMRA subset that responded ex vivo to a pool of DENV-specific peptides (7, 37) from four donors with previous DENV infection (Fig. 2, E and F, fig. S1 , and table S4). Next, we asked what fraction of these DENV-specific TCR clonotypes was present in the general pool of cells present in the T EMRA subset from the same donor. On an average, 64% (n = 4) of the clonally expanded cells in the general T EMRA population carried the DENV-specific TCR clonotypes, and in all donors, one or both of the top two clonally expanded clonotypes in the T EMRA population were always DENVspecific (Fig. 2, E and F, fig. S1 , and table S4), which suggested that most of the clonally expanded cells in the T EMRA population in these individuals were specific for DENV. (Fig. 3C ). Considering some of these donors were previously infected with DENV (DENV + donors) raised the hypothesis that selection and expansion of such TCR clonotypes may be linked to the DENV infection. Even in donors without previous DENV infection (DENV − donors), we observed very high levels of clonal expansion ( Fig. 3C ), suggesting that other infections-perhaps CMV, which is common in the general population-may also contribute to the preferential expansion of some CD4-CTL clones.
CD4-CTLs
Besides the heterogeneity in clonality, we also observed marked variability in the expression of T EMRA -enriched transcripts in CD4-T EMRA cells across the study donors (Fig. 3 , D and E). For several cytotoxicityrelated transcripts, the expression pattern was highly variable across the 12 donors (Fig. 3, D and E). CD4-T EMRA cells from donors with a larger preexisting T EMRA pool and greater clonal expansion displayed more cytotoxic features (Fig. 3D) . In other words, cytotoxicity-related transcripts were expressed in a greater fraction of single cells or at higher mean levels; other T EMRA -enriched transcripts such as ZNF683, PRSS23, FCRL6, and IFIT2 also showed a similar pattern (Fig. 3 , D and E). We confirmed at the protein level that greater proportion of CD4-T EMRA cells expressed cytotoxicity-related molecules CD244, GPR56, GZMB, and PRF1 in donors with larger preexisting T EMRA pool (Fig. 3F) . Therefore, our combined transcriptomic, protein, and TCR analysis suggests that the CD4-T EMRA subset exhibits quantitative and qualitative differences across different donors irrespective of their DENV infection status or geographical location and, in many instances, related to the CD4-CTL function.
CD4-CTL effector cells revealed by single-cell analysis
We next asked whether the heterogeneity observed in the single-cell transcriptomes of CD4-T EMRA was due to the presence of multiple distinct subsets. Four clusters were revealed by unbiased clustering of CD4-T EMRA cells from the 12 study donors (917 cells) using the Seurat software ( Fig. 4A ) (38) ; other methods of clustering also revealed a similar pattern, and no major changes were introduced by technical and batch effects (see figs. S2 and S3, table S1, and Supplementary Materials and Methods) (39) . The proportion of cells in each cluster varied greatly among donors, with marked differences observed between donors from Sri Lanka and the Americas (Fig. 4B , left), suggesting that the nature and type of infections may shape the molecular profiles of CD4-CTLs. Clonal expansion was observed more frequently in cells from clusters 1 and 2 ( Fig. 4B , right, and table S4). 
Clonotype frequency (24 to Single-cell differential gene expression analysis among the four clusters revealed notable differences in their molecular profiles (Fig. 4C,  fig. S4 , A to D, and table S5). IPA and differential expression analysis of the transcripts enriched in clusters 1 and 2 compared with clusters 3 and 4 showed significant overrepresentation of genes encoding products related to cytotoxicity, such as GZMB, GZMH, PRF1, GNLY, NKG7, ZNF683, and FGFBP2 (figs. S4, C and D, and S5 and table S5). Among these two clusters (1, 2), cluster 2 shows further enrichment for the cytotoxicity-related genes (figs. S4A and S5A), which suggested that cells in cluster 2 had a higher cytotoxic potential. Pairwise comparison of the clusters ( fig. S4D and table S5) showed differences in the enrichment of cytotoxicity-related genes among clusters 1 and 2; although several of them were expressed by both the clusters (GZMB, GZMH, GNLY, NKG7, FASLG, and CASP10), many were expressed in a cluster-specific manner (Fig. 4, D and E, fig. S4D , and table S5). On the basis of the differential expression pattern of cytotoxicity-related transcripts in cluster 1 (FADD, IFNG, TNF, IFIT2, LMNA, CD69, FOS, JUN, DUSP1, and DUSP2) and cluster 2 (FGFBP2, SPON2, CX3CR1, GPR56, and PRF1), we hypothesize that their cytotoxic function is preferentially mediated by the FAS/death receptor and perforin pathways, respectively, which requires further functional verification (Fig. 4,  D and E, fig. S4 , A and D, and table S5). donors. Each dot represents a donor. **P < 0.001, ***P < 0.0005, and ****P < 0.0001 from Student's paired two-tailed t test.
Cells in clusters 1 and 2 expressed higher levels of KLRG1 (40-42) and CX3CR1 (7, 43) transcripts, which are linked to effector status of memory cells, and lower levels of CD27 and CD28 transcripts, which encode costimulation molecules (Figs. 4E and 5, A and B) (44, 45) . These results indicate that cells in clusters 1 and 2 have a terminal effector state and hence are CD4-CTL effectors with high cytotoxic potential. Genes linked to cell survival and CD4-CTL function such as PRSS23, SPON2, TCF7 (encodes for TCF1), CRTAM, and ZNF683 (encodes for Hobit) (24, (46) (47) (48) (49) (50) (51) were also highly expressed in single cells from clusters 1 and 2 (Fig. 4E) . The role of ZNF683 (Hobit) (24, 46, 49) and other transcripts (PRSS23, SPON2, and TCF7) (47, 48) in the survival and long-term persistence of these high cytotoxic terminal effector cells deserves further investigation (45) . IFIT2  CCL4  IFNG  IFIT3  ZEB2  CRTAM  CASP8   NKG7  PRF1  GPR56  GZMH  FCRL6  CX3CR1  FGFBP2  SPON2  ZNF683  GZMB  CST7   CDKNA  ZFP36  ZNF331  FOS  GPR13  CD44  TOM1  GATA3  IFNGR1  AQP3  TCF7   IL7R  LEF1  LTB  CD28  CDKN2  PTEN (IL7R or CD127), which is known to play an important role in mediating the long-term homeostatic survival of naive and memory T lymphocytes (Fig. 5A) (52-55) . The mean expression of IL7R transcripts in cluster 4 cells was even higher than that in T CM cells (Fig. 5, A and B) . The opposing expression pattern of KLRG1 and IL7R transcripts in clusters 3 and 4 is similar to that observed in memory precursor effector cells (IL-7R high and KLRG1 − ) described in murine models of resolving acute infections (52, 56) . Transcripts encoding CD27 and CD28 costimulation molecules, lymphotoxin  (LTB), and JUNB TF were also expressed at higher levels in clusters 3 and 4, similar to the pattern observed in T CM cells (Fig. 5, B and C) . However, cells in both clusters 3 and 4 were still markedly different from T CM Given that surface expression of IL-7R (CD127) can be readily determined by flow cytometry, we looked for the presence of potential CD4-CTL precursors within the CD4-T EMRA subset from an independent cohort of healthy donors. For these studies, we capitalized on the La Jolla Institute cohort of 89 healthy donors, of which 15 donors had longitudinal samples (two time points) (104 samples in total). As expected, there was a large variation (0.12 to 15.2%) in the proportion of the CD4-T EMRA subset across the study donors (Fig. 5D) . On the basis of the surface expression pattern of IL-7R, cells in the CD4-T EMRA subset were classified into IL-7R high and IL-7R − (Fig. 5E ). The expression level of IL-7R on IL-7R high T EMRA cells was similar to that observed in T CM and T N (naive T cell) CD4 + T lymphocytes ( Fig. 5E and fig. S5B ). These cells (IL-7R high T EMRA cells) may represent the CD4-CTL precursors defined by our single-cell transcriptome analysis. In longitudinal samples obtained at 3-to 6-month intervals, the proportion of cells in the CD4-T EMRA subset was quite stable (Fig. 5F) ; however, in one donor, we noted a marked (>8-fold) expansion of the CD4-T EMRA subset; this expansion was mainly confined to the IL-7R − T EMRA cells (CD4-CTL effectors), and not the IL-7R high T EMRA (CD4-CTL precursors), perhaps reflecting an expansion of effectors in response to an infection that occurred during the interval period (Fig. 5, F and G) . To further confirm that the IL-7R high T EMRA subset (CD4-CTL precursors) shared the molecular profile of both T CM (long-term memory cells) and cytotoxic cells, we isolated IL-7R high T EMRA and IL-7R − T EMRA (CD4-CTL effectors) along with T CM and T EM subsets and performed RNA-seq in two longitudinal samples from five donors (Fig. 5H) . Consistent with our single-cell cluster analysis (Fig. 5C) , the IL-7R high T EMRA subset shared molecular features of both T CM (memory precursor cells) and cytotoxic cells (IL-7R − T EMRA , CD4-CTL effectors) that were stable over two longitudinal visits (Fig. 5H and  table S6 ). The IL-7R high T EMRA subset (CD4-CTL precursors) expressed both cytotoxicity-related molecules (GPR56 and CD244) and a costimulatory molecule (CD28, T CM -enriched) at the protein level (Fig. 5I) . Together, these results show that cells in the IL-7R high T EMRA subset have properties of memory precursor cells and cytotoxic cells.
The T EMRA subset includes CD4-CTL precursor cells

CD4-CTL precursors share TCRs with CD4-CTL effectors
To verify our hypothesis, we analyzed the overlap in the TCR clonotypes of CD4-CTL effectors (clusters 1 and 2) with those from CD4-CTL precursors (clusters 3 and 4). In a total of 5 of 12 donors, TCR clonotypes were shared between CD4-CTL precursors and effectors ( Figs. 2A and 6A, fig. S6A , and table S4). As examples, in donor #1, 23 of 80 T EMRA cells had the same TCR chain clonotype ( fig. S6A ) as a single cell from precursor cluster (cluster 3); in donor #12, four TCR chain clonotypes were shared between CD4-CTL precursors and effectors (Fig. 6A , clones highlighted in dashed lines with the precursor cells indicated with red arrows). A similar pattern was observed in donors #3, #5, and #6 ( Figs. 2A and 6A and table S4 ). To further support our inference, we constructed cell-state hierarchy maps using the Sincell software (39) for cells in the T CM , T EM , and T EMRA subsets and observed that CD4-CTL effectors clustered closest to the CD4-CTL precursors (Fig. 6B and fig. S6B ). Together, these data lend support to the hypothesis that CD4-CTL effectors were mainly generated in vivo from distinct CD4-CTL precursor cells, although the possibility of arising from memory T EM or T CM cells cannot be excluded.
To support our hypothesis that CD4-CTL effectors are mainly derived from the precursor population, we performed a unique molecular identifier (UMI)-based TCR sequencing (TCR-seq) assays (57) in T CM , T EM , IL-7R high T EMRA (CD4-CTL precursors), and IL-7R − T EMRA (CD4-CTL effectors) subsets from 14 donors (table S7) . Consistent with single-cell TCR analysis (Fig. 2, A and B) , the CD4-CTL precursor and effector cells in the T EMRA subset had highly restricted TCR repertoire, compared with cells in the T CM and T EM subsets, as shown by lower Shannon-Wiener diversity index (Fig. 6C ) (58) , and contained higher percentage of expanded clonotypes (Fig. 6 , D, E and F, left, and fig. S7, left) . A larger fraction of the clonotypes in the CD4-CTL precursor cells relative to T EM and T CM was composed of the expanded clonotypes (frequency, ≥3) present in the CD4-CTL effector cells (Fig. 6E, middle, and fig. S7 , middle). Further, the most expanded clonotype in the CD4-CTL effector cells was observed more often and at higher frequency in CD4-CTL precursor cells relative to T EM and T CM (Fig. 6E, right graphs, and fig. S7 , right graphs).
We also performed TCR-seq in CD4 + T cell memory subsets from five donors who provided longitudinal samples obtained at 3-to 6-month intervals to assess the kinetics of precursor-effector relation. To better assess the relationship between effectors and putative precursors for each donor, we determined the proportion of expanded CD4-CTL effectors clono types from second visit (V2) that were present in the different CD4 + T cell memory subsets at the first visit (V1) (table S8). In four of the five donors analyzed, a greater fraction of the TCR clonotypes detected in CD4-CTL effectors at V2 was shared with cells in the precursor population (IL-7R high T EMRA subset) relative to the T EM or T CM subset at V1 (Fig. 6F, middle, fig. S7 , and table S8). A total of 12 of the CD4-CTL effector clonotypes from V2 were only found in CD4-CTL precursors at V1 but not in the T EM , T CM , or CD4-CTL effectors (table S8) . Together, the kinetic data from the longitudinal samples provided stronger evidence to support the precursor-effector relationship and suggested that the IL-7R high T EMRA subset is the predominant precursor/progenitor for the CD4-CTL effector cells.
Variable number of CD4-CTL precursors across donors
The proportion of CD4-CTL precursors varied greatly among donors, ranging from 3 to 92% of cells in the T EMRA subset (fig. S8A ). To determine whether additional CD4-CTL subsets exist and to definitively assess the presence of CD4-CTL precursors, we analyzed singlecell transcriptomes of 10 times as many cells (>6000 cells) from two donors using the high-throughput 10× genomics platform. The sensitivity of the 10× genomics platform, which uses beads to capture transcripts and also sequences only their 3′ ends (59) , is twofold lower than the Smart-seq2 protocol used to study full-length transcriptomes of the same donors ( fig. S8, B and C) . In donor #2, where 24 of 87 cells (28%) ( fig. S8A) were previously assessed as CD4-CTL precursors, unbiased clustering of more than 3000 single-cell transcriptomes revealed two dominant clusters of ~2000 and ~1000 cells each, implying that sequencing more cells does not necessarily reveal additional clusters (Fig. 7A,  left) . These two clusters differentially expressed transcripts characteristic of CD4-CTL effectors (GZMB and NKG7) and precursors (IL7R, JUNB, and LTB), respectively (Fig. 7B, left, and table S9 ). Even in donor #1, where only 3 of 87 cells (3.4%) ( fig. S8A ) were previously found to be CD4-CTL precursors by full-length transcriptome analysis, we observed a similar proportion of CD4-CTL precursors [116 of 3664 cells (3.2%)] when analyzing more cells by the 10× genomics platform (Fig. 7, A and B, right, and table S9 ). At the single-cell level, CD4-CTL precursors in the CD4-T EMRA subset were distinguished by the high expression levels of IL7R transcripts. The expression pattern of molecules in CD4-CTL precursor and effector cells was further confirmed by single-cell RNA-seq analysis of purified population of IL-7R
high and IL-7R − T EMRA cells (Fig. 7C and table S1 ). precursor cells, intermixed with several features of CD4-CTLs (KLRG1, TBX21, S1PR5, FGFBP2, CCL4, PRF1, GZMH, GNLY,  NKG7, ZEB2 , and GPR56), albeit less prominently expressed than in the CD4-CTL effectors. Bulk and single-cell transcriptome analysis of the purified IL-7R high and IL-7R − T EMRA subset further confirmed our observation from single-cell transcriptome analysis of total T EMRA subset. In several donors, we found cells in the CD4-CTL effector subset that shared their TCR clonotypes with cells in the precursor subset. TCR-seq analysis in longitudinal samples further confirmed this finding and provided more evidence for the relation between CD4-CTL precursors and effectors. Although the kinetic studies support the development of effectors from precursor cells, the nature of our studies in humans limits the definitive assessment of directionality; hence, we cannot completely exclude the possibility that the progenitor cell generated immediately after infection is the cytotoxic effector cell that eventually reverts. By defining the single-cell transcriptional program of CD4-CTL precursor cells, we have identified a number of previously unknown molecules potentially important for their differentiation and function and represent attractive targets for further validation studies.
We showed that surface expression of the IL-7R (CD127) in T EMRA cells defines a subset of cells with the expression of IL-7R as high as that observed in the T CM subset. Given the established role of the IL-7R signaling pathway in homeostatic T cell proliferation and survival, such IL-7R high T EMRA cells are likely to represent the precursors of CD4-T EMRA . The isolation of a CD4-CTL precursor subset based on the surface expression of IL-7R would enable detailed epigenetic studies to define the nature and extent of CD4-CTL reprogramming in such precursor cells. These future studies are likely to provide insights into the molecular mechanisms that govern the early development, differentiation, and function of CD4-CTLs in humans as they transit from naive to memory precursor and effector cells.
The CD4-CTL effector cells displayed a number of known cytotoxicity molecules and previously unknown players (PFN1, PFN1P1, EFHD2, VCL, DIP2A, PLEK, and SYNE1) whose single-cell coexpression pattern suggests an important biological role for these molecules in CD4-CTL function. Further, their transcriptional program suggests that CD4-CTL effectors are terminally differentiated and likely short-lived because they express low levels of the costimulatory molecules CD27 and CD28 and high levels of KLRG1 transcripts (41, 52, (60) (61) (62) . However, we observed marked clonal expansion of CD4-CTL effectors in several donors, suggesting that, compared with other conventional T H effector cells, different molecular mechanisms may operate in CD4-CTL effectors to promote their long-term survival. IL-7R − T EMRA CD4-CTL effectors highly expressed several molecules that are linked to cell survival such as CRTAM, ZNF683 (Hobit), PRSS23, SPON2, and TCF7 (encodes TCF1) (24, (46) (47) (48) (49) (50) (51) . Therefore, we hypothesize that these candidate molecules are likely to confer long-term survival properties to CD4-CTL effectors, which warrants further functional investigation in model organisms.
Overall, our single-cell transcriptomic studies in the human CD4-T EMRA population have uncovered an unprecedented level of heterogeneity, presumably created by the diverse nature of infections and the timing of exposures coupled with genetic diversity among our study donors. We identified a T EMRA subset of precursor CD4-CTLs, whose isolation and further characterization may open avenues for investigating the mechanisms that govern the generation of CD4-CTLs in humans. The stem-like virus-specific long-lived human memory T cell subset originating from T N cells has been described for CD8 compartment, where these cells share the molecular profiles of T N and T CM subsets (63) . Considering the expansion of T EMRA in response to viral infections such as DENV and CMV, it is possible that IL-7R high T EMRA subset (CD4-CTL precursors) may develop from such compartment. Understanding the origins and biology of potentially long-lived CD4-CTL precursors may pave the way for developing strategies to boost durable CD4-CTL immune responses after vaccination against viral infections and cancer. A comprehensive assessment of heterogeneity in pathogen-or vaccine epitope-specific CD4-CTLs by single-cell approaches is likely to yield insights into the nature of protective CD4-CTL response generated against specific pathogens or vaccines.
MATERIALS AND METHODS
Study design
The goal of this study was to use single-cell RNA-seq assay to capture the transcriptome of individual cells in CD4 + T cell memory subsets in human peripheral blood mononuclear cells (PBMCs). Details on the sample collection and processing are described in Supplementary Materials and Methods.
Flow cytometry
Human PBMCs were isolated and stained as described in Supplementary Materials and Methods.
Single-cell RNA-seq
Single-cell RNA-seq was performed as described previously (33, 34) , with some modifications that are described in Supplementary Materials and Methods.
Single-cell RNA-seq and statistical analysis Data processing and analysis were performed using R, Qlucore Omics, and GraphPad Prism, as described in Supplementary Materials and Methods.
TCR-seq and analysis TCR-seq was performed and analyzed as described previously (57, 58) . Details are described in Supplementary Materials and Methods.
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